17:29 EST NeuroSense (NRSN) files $150M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NRSN:
- NeuroSense Shareholders Approve Equity Grants to Directors and CEO to Preserve Cash
- NeuroSense Reports Favorable Safety Profile for PrimeC in Phase 2 Alzheimer’s Trial
- NeuroSense confirms favorable safety, tolerability of Prime C in Phase 2 study
- NeuroSense Completes Data Collection for Alzheimer’s Trial
- NeuroSense Therapeutics Plans Pre-NDS Meeting with Health Canada for ALS Drug